US Stock MarketDetailed Quotes
VRCA Verrica Pharmaceuticals
- 0.995
- +0.005+0.45%
Close Nov 22 16:00 ET
90.07MMarket Cap-540P/E (TTM)
1.020High0.960Low552.84KVolume0.982Open0.990Pre Close551.06KTurnover0.81%Turnover RatioLossP/E (Static)90.56MShares11.41052wk High-2.64P/B68.25MFloat Cap0.70452wk Low--Dividend TTM68.62MShs Float23.290Historical High--Div YieldTTM6.04%Amplitude0.704Historical Low0.996Avg Price1Lot Size
About Verrica Pharmaceuticals Company
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Company Profile
SymbolVRCA
Company NameVerrica Pharmaceuticals
Listing DateJun 15, 2018
Issue Price15.00
Founded2013
CEODr. Jayson Rieger
MarketNASDAQ
Employees100
Fiscal Year Ends12-31
Address44 West Gay Street,Suite 400
CityWest Chester
ProvincePennsylvania
CountryUnited States of America
Zip Code19380
Phone1-434-453-3300
Websitehttp://www.verrica.com
Company Executives
- Name
- Position
- Salary
- Dr. Jayson Rieger
- Director, Chief Executive Officer and President
- --
- John J. Kirby
- Interim Chief Financial Officer and Interim Principal Accounting Officer
- --
- Gary Goldenberg
- Chief Medical Officer
- --
- Christopher G. Hayes
- Chief Legal Officer
- 2.56M
- Paul B. Manning
- Chairman of the Board
- --
- Sean Stalfort
- Director
- --
- Dr. Diem Nguyen, M.B.A.,PhD
- Independent Director
- 99.19K
- Mark A. Prygocki, Sr
- Independent Director
- 119.19K
- Dr. Lawrence Eichenfield, M.D.
- Independent Director
- 119.19K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data